You might also like
Perrigo Company plc is a global leader in providing consumer self-care products and over-the-counter (OTC) health and wellness solutions. The company empowers individuals to proactively manage their health by offering a wide range of accessible, high-quality products. Perrigo operates extensive manufacturing and distribution networks, primarily in the U.S., and collaborates with strategic partners to enhance its market presence.
- Consumer Self-Care Americas (CSCA) - Focuses on consumer self-care products in the U.S. and Canada, offering a variety of OTC health and wellness solutions tailored to these markets.
- Consumer Self-Care International (CSCI) - Provides consumer self-care products outside the U.S. and Canada, with a primary focus on Europe and Australia.
-
Given the current estimates of tariff impacts, can you elaborate on the specific risks if tariffs were to increase unexpectedly and how such scenarios might affect your EPS and gross margins, especially considering your current mitigation actions?
-
With infant formula net sales growing 19% in Q1, what concrete steps will you take to sustain this momentum amid competitive pricing pressures and a shifting regulatory landscape?
-
Considering the mixed performance in organic net sales—highlighted by lost distribution effects in the store brand and prior year Opill stocking benefits—what strategic measures are you implementing to achieve consistent sales growth across all segments?
-
Amid the increased interest in contract manufacturing and your efforts to bring production in-house, how will you ensure that these initiatives do not disrupt your current cost structure or compromise operational efficiency?
-
With the rise in SG&A investments for new product introductions and promotional activities in the context of a challenging macroeconomic environment, what is the expected timeline for these investments to materialize into measurable top-line growth, and how will you assess their ROI?
Competitors mentioned in the company's latest 10K filing.
| Company | Description |
|---|---|
This competitor is mentioned as one of the primary competitors in the self-care product market, competing in various product lines and geographic regions. | |
LNK International, Inc. | This competitor is identified as a key player in the self-care product market, competing with the company in specific product categories. |
PL Developments | This competitor is highlighted as a significant competitor in the self-care product market, particularly in the store brand segment. |
Aurobindo | This competitor is noted as a primary competitor in the self-care product market, with competition varying by product line and region. |
Sun Pharmaceuticals | This competitor is mentioned as a key competitor in the self-care product market, competing in certain categories and regions. |
This competitor is listed as a brand-name pharmaceutical and consumer product company competing in the self-care market. | |
This competitor is identified as a brand-name company competing in the self-care product market. | |
This competitor is mentioned as a major brand-name company in the self-care product market. | |
Reckitt Benckiser | This competitor is highlighted as a significant brand-name company in the self-care product market. |
This competitor is noted as a key player in the self-care product market, particularly in the nutrition segment. | |
Bayer AG | This competitor is mentioned as a major brand-name pharmaceutical and consumer product company in the self-care market. |
Opella | This competitor is identified as a brand-name company competing in the self-care product market. |
This competitor is listed as a significant player in the self-care product market, competing in certain categories. | |
This competitor is noted as a key competitor in the self-care product market, particularly in pharmaceutical categories. | |
This competitor is highlighted as a significant competitor in the self-care product market, competing in various categories. | |
Stada | This competitor is mentioned as a key player in the self-care product market, particularly in the European market. |
| Customer | Relationship | Segment | Details |
|---|---|---|---|
Walmart Inc. | Major retailer | All | 11.9% of FY2024 net sales, i.e. ~$519.4M out of $4,373.4M total |
Recent press releases and 8-K filings for PRGO.
- Shareholders voted on key governance matters at the Annual General Meeting held on May 1, 2025, including the election of directors and advisory votes on executive compensation.
- Matters approved also included the ratification of Ernst & Young LLP as independent auditor for 2025, renewal of board authority for share issuance and statutory pre-emption rights, and an increase in the number of directors.
- Net sales for Q4 2024 totaled $1.14 billion, showing a 1.6% decline year-over-year, with organic growth partly offset by impacts from divested businesses and currency effects.
- Adjusted diluted EPS improved to $0.93, an 8.1% increase from the prior period, though the reported diluted loss was $(0.30) per share.
- The company reversed its operating performance, reporting $114 million in operating income compared to a prior loss, with adjusted operating income rising 16.0% to $194 million.